| NDC Code | 87073-110-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (87073-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 87073-110 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Rapiblyk |
|---|
| Non-Proprietary Name | Landiolol |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20250519 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA217202 |
|---|
| Manufacturer | AOP Health US, LLC |
|---|
| Substance Name | LANDIOLOL HYDROCHLORIDE |
|---|
| Strength | 280 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Adrenergic beta1-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
|---|